Aldeyra Therapeutics
ALDX
ALDX
89 hedge funds and large institutions have $197M invested in Aldeyra Therapeutics in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 32 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
30% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 20
31% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 32
37% less call options, than puts
Call options by funds: $1.6M | Put options by funds: $2.55M
Holders
89
Holding in Top 10
2
Calls
$1.6M
Puts
$2.55M
Top Buyers
| 1 | +$7.72M | |
| 2 | +$3.74M | |
| 3 | +$3.19M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$2.68M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.01M |
Top Sellers
| 1 | -$5.32M | |
| 2 | -$4.14M | |
| 3 | -$3.93M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.49M |
| 5 |
Millennium Management
New York
|
-$3.15M |